From Rich Murray
rmforall [at] att [dot] net
12-24-2
From Norfolk Genetic Information Network (Taken from Welcome to the Spin
Machine by Michael Manville http://www.freezerbox.com/archive/2001/04/biotech/
http://www.freezerbox.com/ )
In 1985 Monsanto (My-Satan) purchased G.D. Searle, the chemical company
that held the patent to aspartame, the active ingredient in NutraSweet.
Monsanto was apparently untroubled by aspartame's clouded past, including
a 1980 FDA Board of Inquiry, comprised of three independent scientists,
which confirmed that it "might induce brain tumors."
http://jahtruth.net/genet.htm
http://jahtruth.net/why.htm
The FDA had actually banned aspartame based on this finding, only to have
Searle Chairman Donald Rumsfeld (currently the Secretary of Defense) vow
to "call in his markers," to get it approved.
On January 21, 1981, the day after Ronald Reagan's inauguration, Searle
re-applied to the FDA for approval to use aspartame in food sweetener,
and Reagan's new FDA commissioner, Arthur Hayes Hull, Jr., appointed a
5-person Scientific Commission to review the board of inquiry's decision.
It soon became clear that the panel would uphold the ban by a 3-2 decision,
but Hull then installed a sixth member on the commission, and the vote
became deadlocked. He then personally broke the tie in aspartame's favor.
Hull later left the FDA under allegations of impropriety, served briefly
as Provost at New York Medical College*, and then took a position with
Burston-Marsteller, the chief public relations firm for both Monsanto
and GD Searle. Since that time he has never spoken publicly about aspartame.
* http://jahtruth.net/heal.htm
The Aspartame/NutraSweet Timeline
http://www.swankin-turner.com/aspartame.html http://www.swankin-turner.com/hist.html
Aspartame/NutraSweet: The History of the Aspartame Controversy
By James Turner, ESQ. Director of the National Institute of Science, Law,
and Public Policy (NISLAPP)
National Institute of Science, Law, and Public Policy 1400 16th Street,
NW, Suite 330, Washington, DC 20036 (202) 462-8800 Fax: (202) 265-6564
nislapp [at] swankin-turner [dot] com
Timeline
December 1965-- While working on an ulcer drug, James Schlatter, a chemist
at G.D. Searle, accidentally discovers aspartame, a substance that is
180 times sweeter than sugar yet has no calories.
Spring 1967-- Searle begins the safety tests on aspartame that are necessary
for applying for FDA approval of food additives.
Fall 1967-- Dr. Harold Waisman, a biochemist at the University of Wisconsin,
conducts aspartame safety tests on infant monkeys on behalf of the Searle
Company. Of the seven monkeys that were being fed aspartame mixed with
milk, one dies and five others have grand mal seizures.
November 1970-- Cyclamate, the reigning low-calorie artificial sweetener
-- is pulled off the market after some scientists associate it with cancer.
Questions are also raised about safety of saccharin, the only other artificial
sweetener on the market, leaving the field wide open for aspartame.
December 18, 1970-- Searle Company executives lay out a "Food and
Drug Sweetener Strategy' that they feel will put the FDA into a positive
frame of mind about aspartame. An internal policy memo describes psychological
tactics the company should use to bring the FDA into a subconscious spirit
of participation" with them on aspartame and get FDA regulators into
the "habit of saying, "Yes"."
This is part of their age-old plan for world domination:-
Extract from the article about The Protocols of The Elders of Zion
In 1492, Chemor, Chief Rabbi of Spain received the following reply from the Grand Sanhedrin (Elders of Zion) to his plea for advice on how to deal with their threatened expulsion under Spanish Law; it illustrates well how the same ancient agenda was still being adhered to by the elect at this time:
'Beloved brethren in Moses (another lie), we have received your letter in which you tell us of the anxieties and misfortunes which you are enduring. We are pierced by as great a pain to hear it as yourselves.
The advice of the Grand Satraps and the Rabbis is the following:
1. As for what you say that the king of Spain obliges you to become Christians: do it, since you cannot do otherwise.
2. As for what you say about the command to despoil you of your property: make your sons merchants that they may despoil, little by little, the Christians of theirs.
3. As for what you say about making attempts on your lives: make your sons doctors and apothecaries (pharmacists/chemists), that they may take away Christian's lives.
4. As for what you say of their destroying your synagogues: make your sons canons and clerics in order that they may destroy their churches.
5. As for the other vexations you complain of: arrange that your sons become advocates and lawyers, and see that they always mix in affairs of State, that by putting Christians under your yoke you may dominate the world and be avenged on them.
6. Do not swerve from this order that we give you, because you will find by experience that, humiliated as you are, you will reach the actuality of power.
(Signed) Prince of the Jews of Constantinople'
(Julio-Inigrez de Medrano - 'La Silva Curiosa' 1608 my emphasis)
Spring 1971-- Neuroscientist Dr. John Olney (whose pioneering work with
monosodium glutamate was responsible for having it removed from baby foods)
informs Searle that his studies show that aspartic acid (one of the ingredients
of aspartame) caused holes in the brains of infant mice. One of Searle's
own researchers confirmed Dr. Olney's findings in a similar study.
February 1973-- After spending tens of millions of dollars conducting
safety tests, the G.D. Searle Company applies for FDA approval and submits
over 100 studies they claim support aspartame's safety.
March 5, 1973-- One of the first FDA scientists to review the aspartame
safety data states that "the information provided (by Searle) is
inadequate to permit an evaluation of the potential toxicity of aspartame".
She says in her report that in order to be certain that aspartame is safe,
further clinical tests are needed.
May 1974-- Attorney, Jim Turner (consumer advocate who was instrumental
in getting cyclamate taken off the market) meets with Searle representatives
to discuss Dr. Olney's 1971 study which showed that aspartic acid caused
holes in the brains of infant mice.
July 26, 1974-- The FDA grants aspartame its first approval for restricted
use in dry foods.
August 1974-- Jim Turner and Dr. John Olney file the first objections
against aspartame's approval.
March 24, 1976-- Turner and Olney's petition triggers an FDA investigation
of the laboratory practices of aspartame's manufacturer, G.D. Searle.
The investigation finds Searle's testing procedures shoddy, full of inaccuracies
and "manipulated" test data. The investigators report they "had
never seen anything as bad as Searle's testing."
January 10, 1977-- The FDA formally requests the U.S. Attorney's office
to begin grand jury proceedings to investigate whether indictments should
be filed against Searle for knowingly misrepresenting findings and "concealing
material facts and making false statements" in aspartame safety tests.
This is the first time in the FDA's history that they request a criminal
investigation of a manufacturer.
January 26, 1977-- While the grand jury probe is underway, Sidley &
Austin, the law firm representing Searle, begins job negotiations with
the U.S. Attorney in charge of the investigation, Samuel Skinner.
March 8, 1977-- G. D. Searle hires prominent Washington insider Donald
Rumsfeld as the new CEO to try to turn the beleaguered company around.
A former Member of Congress and Secretary of Defense in the Ford Administration,
Rumsfeld brings in several of his Washington cronies as top management.
July 1, 1977-- Samuel Skinner leaves the U.S. Attorney's office and takes
a job with Searle's law firm. (see Jan. 26th)
August 1, 1977-- The Bressler Report, compiled by FDA investigators and
headed by Jerome Bressler, is released. The report finds that 98 of the
196 animals died during one of Searle's studies and weren't autopsied
until later dates, in some cases over one year after death. Many other
errors and inconsistencies are noted. For example, a rat was reported
alive, then dead, then alive, then dead again; a mass, a uterine polyp,
and ovarian neoplasms were found in animals but not reported or diagnosed
in Searle's reports.
December 8, 1977-- U.S. Attorney Skinner's withdrawal and resignation
stalls the Searle grand jury investigation for so long that the statue
of limitations on the aspartame charges runs out. The grand jury investigation
is dropped.
June 1, 1979-- The FDA established a Public Board of Inquiry (PBOI) to
rule on safety issues surrounding NutraSweet.
September 30, 1980-- The Public Board of Inquiry concludes NutraSweet
should not be approved pending further investigations of brain tumors
in animals. The board states it "has not been presented with proof
of reasonable certainty that aspartame is safe for use as a food additive."
January 1981-- Donald Rumsfeld, CEO of Searle, states in a sales meeting
that he is going to make a big push to get aspartame approved within the
year. Rumsfeld says he will use his political pull in Washington, rather
than scientific means, to make sure it gets approved.
January 21, 1981-- Ronald Reagan is sworn in as President of the United
States. Reagan's transition team, which includes Donald Rumsfeld, CEO
of G. D. Searle, hand picks Dr. Arthur Hull Hayes Jr. to be the new FDA
Commissioner.
March, 1981-- An FDA commissioner's panel is established to review issues
raised by the Public Board of Inquiry.
May 19, 1981-- Three of six in-house FDA scientists who were responsible
for reviewing the brain tumor issues, Dr. Robert Condon, Dr. Satya Dubey,
and Dr. Douglas Park, advise against approval of NutraSweet, stating on
the record that the Searle tests are unreliable and not adequate to determine
the safety of aspartame.
July 15, 1981-- In one of his first official acts, Dr. Arthur Hayes Jr.,
the new FDA commissioner, overrules the Public Board of Inquiry, ignores
the recommendations of his own internal FDA team and approves NutraSweet
for dry products. Hayes says that aspartame has been shown to be safe
for its' proposed uses and says few compounds have withstood such detailed
testing and repeated close scrutiny.
October 15, 1982-- The FDA announces that Searle has filed a petition
that aspartame be approved as a sweetener in carbonated beverages and
other liquids.
July 1, 1983-- The National Soft Drink Association (NSDA) urges the FDA
to delay approval of aspartame for carbonated beverages pending further
testing because aspartame is very unstable in liquid form. When liquid
aspartame is stored in temperatures above 85 degrees Fahrenheit, it breaks
down into DKP and formaldehyde, both of which are known toxins.
July 8, 1983-- The National Soft Drink Association drafts an objection
to the final ruling which permits the use of aspartame in carbonated beverages
and syrup bases and requests a hearing on the objections. The association
says that Searle has not provided responsible certainty that aspartame
and its' degradation products are safe for use in soft drinks.
August 8, 1983-- Consumer Attorney, Jim Turner of the Community Nutrition
Institute and Dr. Woodrow Monte, Arizona State University's Director of
Food Science and Nutritional Laboratories, file suit with the FDA objecting
to aspartame approval based on unresolved safety issues.
September, 1983-- FDA Commissioner Hayes resigns under a cloud of controversy
about his taking unauthorized rides aboard a General Foods jet. (General
foods is a major customer of NutraSweet) Burson-Marsteller, Searle's public
relation firm (which also represented several of NutraSweet's major users),
immediately hires Hayes as senior scientific consultant.
Fall 1983-- The first carbonated beverages containing aspartame are sold
for public consumption.
November 1984-- Center for Disease Control (CDC) "Evaluation of consumer
complaints related to aspartame use." (summary by B. Mullarkey)
November 3, 1987-- U.S. hearing, "NutraSweet: Health and Safety Concerns,"
Committee on Labor and Human Resources, Senator Howard Metzenbaum, chairman.